|
Friday, December 6, 2024, San Diego, California, 11:30 AM – 1:30 PM PT (2:30 PM – 4:30 PM ET)
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Use of CAR T-Cell Therapy and Bispecific Antibodies in the Management of LymphomaA CME Friday Satellite Symposium and Webcast Preceding the 66th ASH Annual Meeting
Program Schedule — Pacific Time
11:00 AM – 11:30 AM — Registration and Lunch 11:30 AM – 1:30 PM — Educational Meeting Location Manchester Grand Hyatt San Diego 1 Market Place San Diego, California Meeting Room Seaport A-D (Second Level) This event will also be webcast live. Please see Registration tab for details. Faculty
Jennifer Crombie, MD Assistant Professor of Medicine Harvard Medical School Dana-Farber Cancer Institute Boston, Massachusetts Martin Hutchings, MD, PhD Senior Consultant Department of Haematology and Phase 1 Unit Rigshospitalet, Copenhagen University Hospital Professor of Clinical Lymphoma Research Department of Clinical Medicine University of Copenhagen Copenhagen, Denmark Matthew Lunning, DO Associate Professor of Medicine Medical Director, Cellular Therapy Associate Vice Chair of Research Assistant Vice Chancellor for Clinical Research Division of Hematology/Oncology Department of Internal Medicine University of Nebraska Medical Center Omaha, Nebraska Tycel Phillips, MD Associate Professor, Division of Lymphoma Department of Hematology and Hematopoietic Cell Transplantation City of Hope Comprehensive Cancer Center Duarte, California Moderator Jeremy S Abramson, MD, MMSc Director, Center for Lymphoma Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Boston, Massachusetts This activity is supported by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, and Regeneron Pharmaceuticals Inc.
Program Schedule — Pacific Time
11:00 AM – 11:30 AM — Registration and Lunch 11:30 AM – 1:30 PM — Educational Meeting Discussion Topics
Target Audience
CE Credit FACULTY — The following faculty reported relevant financial relationships with ineligible entities: Dr Crombie — Advisory Committees: AbbVie Inc, ADC Therapeutics, Genentech, a member of the Roche Group, Genmab US Inc, Regeneron Pharmaceuticals Inc, Seagen Inc; Consulting Agreement: Genentech, a member of the Roche Group; Contracted Research: AbbVie Inc, Bayer HealthCare Pharmaceuticals, Genentech, a member of the Roche Group, Merck. Prof Hutchings — Advisory Committees and Consulting Agreements: AbbVie Inc, AstraZeneca Pharmaceuticals LP, Genmab US Inc, Janssen Biotech Inc, Merck, Roche Laboratories Inc, Takeda Pharmaceuticals USA Inc; Contracted Research: AbbVie Inc, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Celgene Corporation, Genentech, a member of the Roche Group, Genmab US Inc, Incyte Corporation, Janssen Biotech Inc, Johnson & Johnson Pharmaceuticals, Merck, Novartis, Pfizer Inc, Roche Laboratories Inc, Takeda Pharmaceuticals USA Inc; Data and Safety Monitoring Boards/Committees: Genmab US Inc, Roche Laboratories Inc. Dr Lunning — Consulting Honoraria: AbbVie Inc, Acrotech Biopharma, ADC Therapeutics, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Caribou Biosciences Inc, CRISPR Therapeutics, Daiichi Sankyo Inc, Fate Therapeutics, Genentech, a member of the Roche Group, Genmab US Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Janssen Biotech Inc, Kite, A Gilead Company, Loxo Oncology Inc, a wholly owned subsidiary of Eli Lilly & Company, Nurix Therapeutics Inc, Recordati, Regeneron Pharmaceuticals Inc, Sanofi, Seagen Inc, Vittoria Biotherapeutics; Research Funding: Bristol Myers Squibb, Fate Therapeutics, Sana Biotechnology. Dr Phillips — Advisory Committees: AbbVie Inc, Genentech, a member of the Roche Group, Genmab US Inc, Merck; Consulting Agreements: AbbVie Inc, ADC Therapeutics, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, BeiGene Ltd, Bristol Myers Squibb, Epizyme Inc, Genentech, a member of the Roche Group, Genmab US Inc, Gilead Sciences Inc, Incyte Corporation, Lilly, Pharmacyclics LLC, an AbbVie Company, Seagen Inc, TG Therapeutics Inc; Contracted Research: AbbVie Inc, Genentech, a member of the Roche Group; Steering Committee: Genentech, a member of the Roche Group. MODERATOR — Dr Abramson — Consulting Agreements: AbbVie Inc, ADC Therapeutics, AstraZeneca Pharmaceuticals LP, BeiGene Ltd, Bristol Myers Squibb, Celgene Corporation, Cellectar Biosciences Inc, Foresight Diagnostics, Genentech, a member of the Roche Group, Gilead Sciences Inc, Incyte Corporation, Interius BioTherapeutics, Janssen Biotech Inc, Lilly, Novartis, Roche Laboratories Inc, Seagen Inc; Contracted Research: Bristol Myers Squibb, Celgene Corporation, Cellectis, Genentech, a member of the Roche Group, Merck, Mustang Bio, Regeneron Pharmaceuticals Inc, Seagen Inc, Takeda Pharmaceuticals USA Inc. Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersThis activity is supported by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, and Regeneron Pharmaceuticals Inc. Manchester Grand Hyatt San Diego
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of lymphoma.
There is no fee to participate in this hybrid event. In order to attend the in-person symposium in San Diego, you must also be registered to attend the ASH 2024 Annual Meeting. Preregistration (below) is required as seating is limited for this program. IN-PERSON Registration for clinicians in practice/healthcare professionals
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. IN-PERSON Registrationfor clinicians » IN-PERSON Registration for other/industry professionals*
Please note, a limited number of seats are available to other/industry professionals on a first come, first served basis. IN-PERSON Registrationfor nonclinicians »
* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
LIVE WEBCAST Registration for all professionals
Please note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions. REGISTRATION FOR WEBCAST »Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 15 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. |